Department of Pediatrics (Clinical Immunology and Rheumatology), Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Front Immunol. 2022 May 4;13:856601. doi: 10.3389/fimmu.2022.856601. eCollection 2022.
Inborn errors of immunity (IEIs) are a group of heterogeneous disorders characterized by a broad clinical spectrum of recurrent infections and immune dysregulation including autoimmunity and lymphoproliferation (LP). LP in the context of IEI may be the presenting feature of underlying immune disorder or may develop during the disease course. However, the correct diagnosis of LP in IEI as benign or malignant often poses a diagnostic dilemma due to the non-specific clinical features and overlapping morphological and immunophenotypic features which make it difficult to treat. There are morphological clues to LP associated with certain IEIs. A combination of ancillary techniques including EBV-associated markers, flow cytometry, and molecular assays may prove useful in establishing a correct diagnosis in an appropriate clinical setting. The present review attempts to provide comprehensive insight into benign and malignant LP, especially the pathogenesis, histological clues, diagnostic strategies, and treatment options in patients with IEIs.
先天性免疫缺陷(IEI)是一组异质性疾病,其特征是广泛的临床复发性感染和免疫失调谱,包括自身免疫和淋巴增殖(LP)。在 IEI 背景下,LP 可能是潜在免疫紊乱的首发表现,也可能在疾病过程中发展。然而,由于非特异性临床特征和重叠的形态学和免疫表型特征,正确诊断 IEI 中的 LP 是良性还是恶性常常构成诊断难题,这使得治疗变得困难。与某些 IEI 相关的 LP 存在形态学线索。包括 EBV 相关标志物、流式细胞术和分子检测在内的辅助技术的组合可能在适当的临床环境中有助于确立正确的诊断。本综述试图提供对良性和恶性 LP 的全面深入了解,特别是 IEI 患者的发病机制、组织学线索、诊断策略和治疗选择。